Under the arrangement announced Nov. 3, 3M will contribute a nominal total of $7.35 billion between 2026 and 2034. The company calculated the present value of those contributions at $5.8 billion.

Settlement Covers Most Current Claims

3M said the agreement addresses approximately 99% of current PFAS-related personal-injury claims inside and outside the AFFF multidistrict litigation.

Approximately 115,000 to 120,000 plaintiffs are eligible to participate. The actual amount ultimately paid and the timing of payments remain subject to participation thresholds and other terms.

Individuals entering the settlement must enroll and provide 3M with releases covering PFAS-related personal-injury claims they have asserted or could assert. The company’s SEC filing describes the agreement as structured to encourage participation and resolve the vast majority of the claims at issue.

The arrangement also establishes mechanisms for managing remaining and future claims. Those include a $680 million reserve within the total financial commitment and an anticipated court order addressing evidentiary and timing requirements for plaintiffs who may seek to litigate in the future.

The agreement is not an admission of liability or wrongdoing. 3M said it is prepared to continue defending itself if specified settlement requirements are not met.

Payments Extend Through 2034

The payment schedule begins with $50 million in 2026. No payment is scheduled for 2027, and approximately 20% of the total is due during the final two years.

3M said the structure was designed to align the AFFF payments with its remaining obligations under other legacy settlements.

The company expects to record a $5.8 billion pre-tax charge during the fourth quarter of 2026, representing the present value of the contributions. The charge will be treated as a special item in its adjusted results and does not change 3M’s previously issued annual guidance.

PFAS Manufacturing and Legacy Claims

3M said the legacy AFFF claims primarily concern PFAS compounds it announced in 2000 that it would phase out.

The company subsequently announced in 2022 that it would discontinue manufacturing all PFAS globally by the end of 2025. According to 3M, that manufacturing exit has been completed.

The company also said it continues investing in water-treatment and remediation work at sites where it historically manufactured PFAS.

Although this litigation centers on AFFF rather than conventional paint and coatings products, the scale of the agreement is significant for specialty chemical suppliers and coatings formulators tracking PFAS litigation, reporting requirements, regulatory restrictions and reformulation risk.

The settlement should not be interpreted as resolving every PFAS claim or establishing liability across every PFAS chemistry or application. Participation requirements, future claims and other environmental matters remain outside a simple blanket resolution.

Sources: 3M Reaches Broad Resolution of AFFF Personal Injury Litigation, 3M Form 8-K, Nov. 3, 2026, 3M Master Settlement Agreement

The agreement illustrates the continuing financial and operational consequences associated with legacy PFAS use as coatings and chemical companies evaluate reporting obligations, manufacturing processes and alternatives.